Showing results (101-110 of 279) with videos related to
Sort By:
Pageof 28
Journal of Clinical Hypertension (Greenwich, Conn.)|January 6, 2010
Comparison of office, ambulatory, and home blood pressure antihypertensive response to atenolol and hydrochlorthiazideAmber L Beitelshees, Yan Gong, Kent R Bailey, et al.Pharmacogenetics and Genomics|June 18, 2010
Lack of association between polymorphisms in STK39, a putative thiazide response gene, and blood pressure response to hydrochlorothiazideJulio D Duarte, Maximilian T Lobmeyer, Zhiying Wang, et al.Metabolites|September 26, 2021
Metabolomics Signature of Plasma Renin Activity and Linkage with Blood Pressure Response to Beta Blockers and Thiazide Diuretics in Hypertensive European American PatientsMai Mehanna, Caitrin W McDonough, Steven M Smith, et al.Kidney International|September 29, 2023
A novel multi-ancestry proteome-wide Mendelian randomization study implicates extracellular proteins, tubular cells, and fibroblasts in estimated glomerular filtration rate regulationMatthew B Lanktree, Nicolas Perrot, Andrew Smyth, et al.Clinical Journal of the American Society of Nephrology : CJASN|February 19, 2021
Patients with Protein-Truncating PKD1 Mutations and Mild ADPKDMatthew B Lanktree, Elsa Guiard, Pedram Akbari, et al.Journal of the American Society of Nephrology : JASN|December 7, 2016
Urine Osmolality, Response to Tolvaptan, and Outcome in Autosomal Dominant Polycystic Kidney Disease: Results from the TEMPO 3:4 TrialOlivier Devuyst, Arlene B Chapman, Ron T Gansevoort, et al.American Journal of Hypertension|August 21, 2010
Plasma renin activity predicts blood pressure responses to beta-blocker and thiazide diuretic as monotherapy and add-on therapy for hypertensionStephen T Turner, Gary L Schwartz, Arlene B Chapman, et al.Kidney International|April 5, 2003
Recurrence of intracranial aneurysms in autosomal-dominant polycystic kidney diseaseMark M Belz, Godela M Fick-Brosnahan, Richard L Hughes, et al.Clinical Journal of the American Society of Nephrology : CJASN|February 26, 2016
Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage: Results from the TEMPO 3:4 TrialVicente E Torres, Eiji Higashihara, Olivier Devuyst, et al.Journal of the American Heart Association|February 14, 2024
Circulating microRNA Biomarkers of Thiazide Response in HypertensionLakshmi Manasa S Chekka, Marwa Tantawy, Taimour Langaee, et al.Pageof 28